Q2 2025 Brady Corp Earnings Call

In This Article:

Participants

Ann Thornton; Chief Financial Officer, Chief Accounting Officer, Treasurer; Brady Corp

Russell Shaller; President, Chief Executive Officer, Director; Brady Corp

Keith Halsam; Analyst; Northcoast Research

Steve Ferazani; Analyst; Sidoti

Presentation

Operator

Good day and thank you for standing by. Welcome to the Q2 2025 Brady Corporation Earnings Conference Call. (Operator instructions)
I'd like to hand the conference over to your speaker today, Ann Thornton, CFO.

Ann Thornton

Thank you. Good morning and welcome to the Brady Corporation fiscal 2025 second quarter earnings conference call. The slides for this morning's call are located on our website at www.bradyid.com/investors. We will begin our prepared remarks on slide number 3.
Please note that during this call, we may make comments about forward-looking information. Words such as expect, will, may, believe, forecast, and anticipate are just a few examples of words identifying a forward-looking statement. It's important to note that forward-looking information is subject to various risk factors and uncertainties which could significantly impact expected results.
Risk factors were noted in our news release this morning and in Brady's fiscal 2024 Form 10K, which was filed with the SEC in September. Also, please note that this teleconference is copyrighted by Brady Corporation and may not be rebroadcast without the consent of Brady. We will be recording this call and broadcasting it on the internet. As such, your participation in the Q&A session will constitute your consent to being recorded.
I'll now turn the call over to Brady's President and Chief Executive Officer, Russell Shaller.

Russell Shaller

Thank you for joining us today. We released our fiscal 2025 second quarter financial results this morning, and I'm pleased to report another quarter of organic sales growth and improved profit. We grew organic sales 2.6%. Sales from acquisitions were up 10.2%, and we grew adjusted earnings per share by 7.5% in the quarter.
Our Americas and Asia region reported another extremely strong quarter with organic sales growth of 4.3% and adjusted operating income growth of 12%. I'm incredibly pleased with our organic sales growth in Americas and Asia, especially in light of the current macroeconomic or industrials.
Our Europe and Australia region is operating in a tough environment as well, which reflected in our results with a slight organic decline of 0.8% in the quarter. Overall, our teams are executing and we continue to invest in new product development with our focus on long term sales growth. I've been looking forward to the announcement of a very exciting new printer this quarter, which is our I-7500 industrial label printer.
This printer is the first of its kind for Brady because it's designed for both high volume and high mix labeling. The I-7500 has the ability to print on over 4,000 individual stock labels, parts, and ribbons, as well as on more than 80 unique adhesive materials. This printer incorporates Brady's proprietary label sense technology which automatically calibrates the machine for the wide variety of adhesive materials that can run through it, which means the user has next to zero set up time and no wasted labels.
The I-7500 includes a 7-inch touch screen that guides the user through the label printing process, making the printer incredibly easy to use for a wide variety of printing applications ranging from high performance heat resistance labels that can withstand solvents in extreme temperatures. To customize QA inspection labels and factory seals, to aerospace grade, wire identification, and many more. This is the fastest and most versatile printer we've designed to date, and we believe it will be an incredible efficiency tool for our customers in a wide variety of end markets.
We have more exciting new products planned for this year and next year, which we believe will continue to add to our growth into the long term. This quarter we grew adjusted earnings per share while increasing our investments in both research and development and in our sales force. R&D increased by more than 11% this quarter, which came from investment in both our organic business as well as from the acquisition of Gravotech.
Where we've identified some excellent opportunities from a product development standpoint. Now I'll turn the call over to Ann to provide more details on our financial results.